Back
ESC Professional Premium Access

High long-term persistence to evolocumab treatment regimens in European clinical practice: analysis of the HEYMANS registry

Session: Current issues in lipid-lowering therapy
Topic: Lipid-Lowering Agents
Speaker: Doctor M. Sibartie (Uxbridge, GB)
Event: ESC Congress 2022

Congress Presentation

About the speaker

Doctor Mahendra Sibartie

Amgen, Uxbridge (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Efficacy and safety of pemafibrate versus bezafibrate in coronary artery disease patients receiving statin treatment: a randomized, open-label, cross-over study

Speaker: Doctor A. Nakamura (Morioka, JP)

Access
Abstract
Slides
Thumbnail

LDL levels and long-term all-cause mortality in patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.

Speaker: Professor M. Banach (Lodz, PL)

Access
Abstract
Slides
Thumbnail

Preliminary results from REALITY: a nation-wide study of a database with 1.8 million real-life patients to study atherosclerotic cardiovascular disease and familial hypercholesterolemia in Spain

Speaker: Professor V. Barrios (Madrid, ES)

Access
Abstract
Slides
Thumbnail

Statin therapy in children with familial hypercholesterolemia: A meta-analysis.

Speaker: Doctor J. Lewek (Lodz, PL)

Access
Abstract
Slides
Thumbnail

Low-density lipoprotein cholesterol target attainment among statin-naive Chinese atherosclerotic vascular disease patients

Speaker: Ms H. Sun (Shatin, HK)

Access
Abstract
Slides
Thumbnail

Access the full session

Current issues in lipid-lowering therapy

Speakers: Doctor M. Sibartie, Doctor A. Nakamura, Professor M. Banach, Professor V. Barrios, Doctor J. Lewek...
Access
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb